|
CNIH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.213100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.15500000000568E-05 |
| Normal-vs-Stage2 |
9.013500E-02 |
| Normal-vs-Stage3 |
7.247600E-01 |
| Normal-vs-Stage4 |
3.941400E-01 |
| Stage1-vs-Stage2 |
4.517400E-01 |
| Stage1-vs-Stage3 |
2.654500E-02 |
| Stage1-vs-Stage4 |
6.516900E-03 |
| Stage2-vs-Stage3 |
3.203200E-01 |
| Stage2-vs-Stage4 |
6.667700E-02 |
| Stage3-vs-Stage4 |
3.090600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.435800E-04 |
| Normal-vs-AfricanAmerican |
5.943600E-02 |
| Normal-vs-Asian |
6.451000E-01 |
| Caucasian-vs-AfricanAmerican |
3.714000E-01 |
| Caucasian-vs-Asian |
6.130000E-02 |
| AfricanAmerican-vs-Asian |
1.923830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.77201999999044E-05 |
| Normal-vs-Female |
8.220000E-01 |
| Male-vs-Female |
6.964700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.168400E-02 |
| Normal-vs-Extreme_Weight |
4.02109999997347E-06 |
| Normal-vs-Obese |
3.944300E-02 |
| Normal-vs-Extreme_Obese |
9.696000E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.462300E-02 |
| Normal_Weight-vs-Obese |
8.279200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.048400E-01 |
| Extreme_Weight-vs-Obese |
6.375700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.580400E-01 |
| Obese-vs-Extreme_Obese |
3.802200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.046600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.920100E-03 |
| Normal-vs-Age(61-80Yrs) |
1.598210E-04 |
| Normal-vs-Age(81-100Yrs) |
1.088330E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.226200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.395900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.338160E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.169800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.377400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.518800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.88324000000017E-05 |
| Normal-VS-Type2 PRCC |
1.020380E-01 |
| Normal-VS-KIRP CIMP |
1.955000E-01 |
| Normal-VS-Unclassified PRCC |
2.528000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.410500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.417000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
5.514000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.904110E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.777600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.978000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.137200E-03 |
| Normal-vs-N1 |
4.184800E-01 |
| Normal-vs-N2 |
1.141580E-01 |
| N0-vs-N1 |
1.080050E-02 |
| N0-vs-N2 |
9.785800E-01 |
| N1-vs-N2 |
2.878000E-01 |
|
|
